Andrew Hollman Meyer sold $2.3M of Janux Therapeutics (JANX)

Executed Sep 27 2024, disclosed Sep 27 2024, the same day.

Value, as filed

$2.3M

50,000 sh × $45.96

Executed

Sep 27 2024

the trade date, as filed

Disclosed

Sep 27 2024

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AM Andrew Hollman Meyer Chief Business Officer profile →

Andrew Hollman Meyer (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in JANX. The largest single filing was $501K of JANX (16,665 sh × $30.06, as filed), executed Oct 28 2025.

The name

JANX JANX JANX · 18 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Hollman Meyer in JANX

JANXSALE Janux Therapeutics, Inc. $501K
16,665 sh × $30.06
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $100K
3,334 sh × $30.00
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $102K
2,418 sh × $42.08
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $664K
12,134 sh across 3 lots
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET